ketobemidone (Ketogan) Report issue

Small molecule Experimental
AACT ChEMBL DrugBank Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now
Ketobemidone, sold under the brand name Ketogan among others, is a powerful synthetic opioid painkiller. Its effectiveness against pain is in the same range as morphine, and it also has some NMDA-antagonist properties imparted, in part, by its metabolite norketobemidone. This may make it useful for some types of pain that do not respond well to other opioids. It is marketed in Denmark, Iceland, Norway and Sweden and is used for severe pain.   Wikipedia

Chemistry

  • SMILES: CCC(=O)C1(CCN(C)CC1)c2cccc(O)c2
  • InChIKey: ALFGKMXHOUSVAD-UHFFFAOYSA-N
  • Mol. Mass: 247.34
  • ALogP: 2.33
  • ChEMBL Molecule:
    ketobemidone  
More Chemistry

Pharmacology

Alternative names

1-(4-(3-hydroxyphenyl)-1- methyl-4-piperidinyl)-1-propanone | 1-(4-(m-hydroxyphenyl)-1-methyl-4-piperidyl)-1-propanone | cetobemidon | cetobemidone | cliradon | cliradone | ketobemidone | ketobemidone hydrochloride

Organizations (1)

Research & Development (1)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (3)

Approved Indications (1)


 

Pain

Experimental Indications - Clinical Trial Phases 1-4 (3)


 

Hernia, Inguinal (Phase 4)

Pain ()

Pain, Postoperative (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial Organizations: 1

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue